Chou Chiahung, McDaniel Cassidi C, Abrams John David, Farley Joel F, Hansen Richard A
Department of Health Outcomes Research and Policy, Auburn University, Harrison School of Pharmacy, 4306 Walker Building,, Auburn, AL, 36849, USA.
Department of Medical Research, China Medical University Hospital, Taichung City, Taiwan.
Psychiatr Q. 2021 Jun;92(2):587-600. doi: 10.1007/s11126-020-09828-0.
Patients with comorbid mental health and chronic conditions often receive care from both psychiatrists and primary care physicians (PCPs). The introduction of multiple providers into the care process introduces opportunities for disruptions in care continuity. The purpose of this study was to explore psychiatrists' and PCPs' comfort prescribing, along with their comfort having other physician specialties prescribe medications for cardiometabolic, psychiatric, and neurological/behavioral conditions. This cross-sectional study utilized an online, validated, pilot-tested, anonymous survey to examine prescribing practices of psychiatrists and PCPs. Eligible participants included physicians with medical degrees, U.S. prescribing authority, and active patient care for ≥2 days/week. Outcomes of interest were physicians' self-comfort and cross-specialty comfort (other specialists prescribing mutual patients' medications) prescribing cardiometabolic, psychiatric, and neurological/behavioral medications. Comfort prescribing was measured using 7-point Likert scales. Discrepancies in comfort were analyzed using student's, one-sample, and paired t-tests. Multiple linear regressions examined associations between physician practice characteristics and physicians' comfort-level prescribing cardiometabolic and psychiatric medication categories. Among 50 psychiatrists and 50 PCPs, psychiatrists reported significantly lower self-comfort prescribing cardiometabolic medications (mean ± SD = 2.99 ± 1.63 vs. 6.77 ± 0.39, p < 0.001), but significantly higher self-comfort prescribing psychiatric medications (mean ± SD = 6.79 ± 0.41 vs. 6.00 ± 0.88, p < 0.001) and neurological/behavioral medications (mean ± SD = 6.48 ± 0.74 vs. 5.56 ± 1.68, p < 0.001) than PCPs. After adjusting for covariates, physician specialty was strongly associated with self-comfort prescribing cardiometabolic and psychiatric medication categories (both p < 0.001). Differences between self-comfort and cross-specialty comfort were identified. Because comfort prescribing medications differed by physician type, incorporating psychiatrists through collaborative methods with PCPs could potentially ensure comfort among physicians when initiating medications.
患有合并精神健康问题和慢性病的患者通常会同时接受精神科医生和初级保健医生(PCP)的治疗。在治疗过程中引入多个医疗服务提供者会带来护理连续性中断的风险。本研究的目的是探讨精神科医生和初级保健医生在开具处方时的舒适度,以及他们对于让其他专科医生为患有心脏代谢、精神和神经/行为疾病的患者开具药物的接受程度。这项横断面研究采用了一项经过验证、预先测试且匿名的在线调查,以检查精神科医生和初级保健医生的处方行为。符合条件的参与者包括拥有医学学位、具有美国处方权且每周至少有2天积极参与患者护理的医生。研究关注的结果是医生在开具心脏代谢、精神和神经/行为药物处方时的自我舒适度以及跨专科舒适度(其他专科医生为共同患者开具药物)。使用7点李克特量表来衡量开具处方的舒适度。使用学生t检验、单样本t检验和配对t检验分析舒适度的差异。多元线性回归分析了医生的执业特征与医生在开具心脏代谢和精神药物类别处方时的舒适度之间的关联。在50名精神科医生和50名初级保健医生中,精神科医生报告在开具心脏代谢药物处方时的自我舒适度显著较低(平均值±标准差=2.99±1.63 vs. 6.77±0.39,p<0.001),但在开具精神药物处方时的自我舒适度显著较高(平均值±标准差=6.79±0.41 vs. 6.00±0.88,p<0.001),在开具神经/行为药物处方时的自我舒适度也显著较高(平均值±标准差=6.48±0.74 vs. 5.56±1.68,p<0.001)。在调整协变量后,医生的专业与开具心脏代谢和精神药物类别处方时的自我舒适度密切相关(均p<0.001)。研究发现了自我舒适度和跨专科舒适度之间的差异。由于不同类型医生开具处方的舒适度不同,通过与初级保健医生合作的方式纳入精神科医生可能会在开始用药时确保医生之间的舒适度。